UF Health Shand’s Hospital 4% merit increase2018 · UF Health
a. 2018 UF Health Shand’s Hospital 10-year service2018 · UF Health
d. UF Health Shand’s Physician Customer Service Award2015 · UF Health
UF Health Shand’s Patient Recognition Award2015 · UF Health
Juvenile Arthritis Connect Day Medical Honoree2014 · Arthritis Foundation, Florida Chapter
Juvenile Arthritis Walk Honorary Doctor2011 · Arhtritis Foundation, Florida Chapter
Juvenile Arthritis Walk Honorary Doctor2010 · Arthritis Foundation, Florida Chapter
MDT7400 Elect Top/Pediatrics
Pediatric RheumatologyAmerican Board of Pediatrics
- Pediatric Rheumatology
Areas of Interest
- Systemic lupus erythematosus
Open Researcher and Contributor ID (ORCID)
Impact of systemic juvenile idiopathic arthritis/Still’s disease on adolescents as evidenced through social media posts
Open Access Rheumatology: Research and Reviews. Volume 10:73-81 [DOI] 10.2147/oarrr.s165010.
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
Pediatric rheumatology online journal. 15(1) [DOI] 10.1186/s12969-017-0174-0. [PMID] 28610606.
Tocilizumab in the Treatment of Refractory Uveitis in Children
Annals of the Rheumatic Diseases. 73(2):588-589 [DOI] 10.1136/annrheumdis-2014-eular.3773.
B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease.
The Journal of pediatrics. 163(3):847-54.e1 [DOI] 10.1016/j.jpeds.2013.03.002. [PMID] 23601496.
Pediatric Rheumatology Practitioners Experience With Biologics in Juvenile Dermatomyositis: Survey Results.
Arthritis and Rheumatism. 64:S119-S120
Selection and Validation of Pediatric Rheumatology Educational Objectives for Pediatric Residency Core Curriculum
Arthritis and Rheumatism. 58
Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease.
Arthritis and rheumatism. 55(5):823-5 [PMID] 17013844.
Jul 2021 ACTIVE
Real-World Treatment Patterns and Outcomes in Patients with Hemophagocytic Lymphohistiocytosis (HLH) and other Clinical Conditions Treated with Emapalumab across Treatment Centers in the US
Role: Principal Investigator
Masters of Science2005 · University of Southern California
Medical Degree1998 · SUNY Health Science Center
Residency – Pediatrics1998 · Orlando Regional Healthcare System